GLP1R and atherosclerosis: In a mouse study, GLP-1 RA therapy was also found to delay the progression of atherosclerosis through AMP-activated protein kinase (AMPK)-dependent arrest of angiotensin-II-induced vascular smooth muscle cell (VSMC) proliferation [118].